Sequana Medical Investor Presentation 2022

Sequana Medical presented its investor deck in February 2022 detailing innovations in treating diuretic-resistant fluid overload. The presentation covers the alfapump® system for refractory ascites and DSR® therapy, both addressing critical unmet needs in fluid management.